BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 436307)

  • 1. Dopamine is a physiological regulator of thyrotrophin (TSH) secretion in normal man.
    Scanlon MF; Weightman DR; Shale DJ; Mora B; Heath M; Snow MH; Lewis M; Hall R
    Clin Endocrinol (Oxf); 1979 Jan; 10(1):7-15. PubMed ID: 436307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of circadian thyrotropin rhythms and thyroid hormone levels in euthyroid subjects.
    Scanlon MF; Weetman AP; Lewis M; Pourmand M; Rodriguez-Arnao MD; Weightman DR; Hall R
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1251-6. PubMed ID: 7440694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaba-ergic and dopaminergic regulation of thyroid stimulating hormone. Effects of baclofen and metoclopramide.
    Elias AN; Szekeres AV; Stone S; Weathersbee P; Valenta LJ; Haw T
    Horm Res; 1984; 19(3):171-5. PubMed ID: 6425188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related alterations in pulsatile secretion of TSH: role of dopaminergic regulation.
    Greenspan SL; Klibanski A; Rowe JW; Elahi D
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E486-91. PubMed ID: 1900670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral and intravenous TRH and metoclopramide on PRL and TSH secretion in women.
    Kauppila A; Ylikorkala O
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):617-23. PubMed ID: 6819904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridostigmine and metoclopramide do not restore the TSH response to TRH inhibited by L-thyroxine treatment in children with goiter.
    Radetti G; Bernasconi S; Bozzola M; Volta C; Tonini G; Gentili L; Rigon F
    J Endocrinol Invest; 2000 Dec; 23(11):744-7. PubMed ID: 11194708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dopamine and a dopamine D-1 receptor agonist on pulsatile thyrotrophin secretion in normal women.
    Boesgaard S; Hagen C; Hangaard J; Andersen AN; Eldrup E
    Clin Endocrinol (Oxf); 1990 Apr; 32(4):423-31. PubMed ID: 1971778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dopaminergic blockade on serum TSH and prolactin levels in thyrotoxicosis.
    Swart S; O'Malley BP; Vora J; Barnett DB; Rosenthal FD
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):330-5. PubMed ID: 6429989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dopaminergic inhibition on serum levels of thyrotrophin and prolactin in patients with hypothyroidism before and after prolonged oral administration of TRH.
    Frey HM; Haug E
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):183-8. PubMed ID: 6415988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate thyrotrophin secretion, increased dopaminergic tone and preservation of the diurnal rhythm in serum TSH.
    Magee B; Sheridan B; Scanlon MF; Atkinson AB
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):209-15. PubMed ID: 3085996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are fasting-induced effects on thyrotropin and prolactin secretion mediated by dopamine?
    Röjdmark S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1266-70. PubMed ID: 6404923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of metoclopramide on calcium inhibition of thyrotropin response to thyrotropin-releasing hormone.
    Röjdmark S; Andersson DE
    J Clin Endocrinol Metab; 1982 May; 54(5):998-1001. PubMed ID: 6801079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prolactin and thyrotrophin secretion following oral metoclopramide: dose-response relationships.
    Healy DL; Burger HG
    Clin Endocrinol (Oxf); 1977 Sep; 7(3):195-201. PubMed ID: 908151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholaminergic interactions in the regulation of thyrotropin (TSH) secretion in man.
    Scanlon MF; Rodriguez-Arnao MD; Pourmand M; Shale DJ; Weightman DR; Lewis M; Hall R
    J Endocrinol Invest; 1980; 3(2):125-9. PubMed ID: 7391520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyproheptadine on thyrotrophin and prolactin secretion in normal man.
    Golstein J; Vanhaelst L; Bruno OD; L'Hermite M
    Acta Endocrinol (Copenh); 1979 Oct; 92(2):205-13. PubMed ID: 115197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation by nitric oxide of TRH-, but not metoclopramide-stimulated TSH secretion in humans.
    Coiro V; Volpi R; Chiodera P
    Neuroreport; 1995 May; 6(8):1174-6. PubMed ID: 7662901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man.
    Sowers JR; Carlson HE; Brautbar N; Hershman JM
    J Clin Endocrinol Metab; 1977 Feb; 44(2):237-41. PubMed ID: 402375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone.
    Eskildsen PC; Kirkegaard CB
    J Endocrinol Invest; 1985 Oct; 8(5):427-31. PubMed ID: 3935709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Uesato T; Kato K; Shima K
    Endocrinol Jpn; 1985 Jun; 32(3):369-73. PubMed ID: 4042992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.